Primary Site >> Colorectal Cancer

Gene >> TACR1

  • 2000
  • 2010
  • 2011
  • 2012
  • 2015
  • 2016
  • 2017
Ref: Pronounced substance P innervation in irradiation-induced enteropathy--a study on human colon.
PMID: 10706946
Ref: The NK-1 receptor antagonist aprepitant as a broad spectrum antitumor drug.
PMID: 19148578
Ref: The broad-spectrum antitumor action of cyclosporin A is due to its tachykinin receptor antagonist pharmacological profile.
PMID: 20542069
Ref: Effect of a neurokinin-1 receptor antagonist in a rat model of colitis-associated colon cancer.
PMID: 20944107
Ref: Truncated neurokinin-1 receptor is increased in colonic epithelial cells from patients with colitis-associated cancer.
PMID: 21969570
Ref: Association of genetic variants in tachykinins pathway genes with colorectal cancer risk.
PMID: 22733436
Ref: Immunohistochemical expression of SP-NK-1R-EGFR pathway and VDR in colonic inflammation and neoplasia.
PMID: 25684939
Ref: Targeting the neurokinin-1 receptor inhibits growth of human colon cancer cells.
PMID: 25998227
Ref: Neurokinin-2 receptor polymorphism predicts lymph node metastasis in colorectal cancer patients.
PMID: 26137002
Ref: High expression of substance P and its receptor neurokinin-1 receptor in colorectal cancer is associated with tumor progression and prognosis.
PMID: 27366097
Ref: Recent developments in the clinical pharmacology of rolapitant: subanalyses in specific populations.
PMID: 28919712
Ref: Difference in expression of two neurokinin-1 receptors in adenoma and carcinoma from patients that underwent radical surgery for colorectal carcinoma.
PMID: 28927139